Letters to the Editor

Letters to The Editor

Lisa Schulmeister

Peter C. Pieslor

CJON 2003, 7(1), 12-12. DOI: 10.1188/03.CJON.12

In a recent “Clinical Q&A” titled “Handling and Disposal of Monoclonal Antibodies,” the author reviewed guidelines for your readers (Estes, 2002). The manufacturers are not correct in Table 1 on page 290. Zevalin® is manufactured by IDEC Pharmaceuticals Corporation in San Diego, CA. Rituxan® is comarketed by IDEC Pharmaceuticals Corporation and Genentech, Inc., in South San Francisco, CA.

Members Only
Not a current ONS member or journal subscriber?

Purchase This Article

Receive a PDF to download and print.